The global hepatitis therapeutics market size was valued at USD 16.3 billion in 2023 and is projected to reach USD 20.84 billion by 2030, growing at a CAGR of 3.7% from 2024 to 2030.  The growth of this market is being driven by several factors, including the rising number of hepatitis cases worldwide, the increasing prevalence of autoimmune disorders, and the consistent rise in...